Partnerships 2011 Highlight: Implement Changes to Adapt to the Increased Cost of Drug Development

This week, we take a look at the highlights from David Windley's 2011 Partnerships In Clinical Trials Presentation, "Implement Changes to Adapt to the Increased Cost of Drug Development."  In his presentation, he covered looks at the challenges faced by Pharma companies today in the evolving landscape of the world health market.

Watch highlights from his presentation here:



This year, at Partnerships in Clinical Trials 2012, David will be joining us again as a panelist for the "Wall Street and Private Equity Perspectives—Economic Outlook on Investment Areas, Growth Opportunities, and the Outsourcing Industry" panel taking place Tuesday, March 6, 2012.  Joining David will be Jeffrey McMullen, President & CEO, Pharmanet/ i3, Jonathan Leff, Warburg Pincus, Board Venture Capital Association; Eric Coldwell, Managing Director, Robert W. Baird & Co.; and Michael A. Martorelli, CFA, Director, Fairmount Partners.  For more information on this session, download the brochure here.  And when you register to join us at the 21st Annual Partnerships in Clinical Trials, mention code XP1700BLOG and you'll receive 15% off the standard rate !